PAI
BIO icon

Pittenger & Anderson Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pittenger & Anderson Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 444
2022
Q3 		$0 Hold
1
– – ﹤0.01% 456
2022
Q2 		$0 Hold
1
– – ﹤0.01% 434
2022
Q1 		$1K Buy
+1
New +$603 ﹤0.01% 437

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Pittenger & Anderson Inc's BIO Position: Q4 2022 in Review

Pittenger & Anderson Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 1 share.

Pittenger & Anderson Inc first reported a position in BIO in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 471 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Pittenger & Anderson Inc reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 1 Bio-Rad Laboratories Class A share in Q4 2022.
  • Pittenger & Anderson Inc first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 3 quarters.
  • Pittenger & Anderson Inc's Bio-Rad Laboratories Class A position peaked at $1K in Q1 2022.
  • 471 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2022, filed 10 Feb 2023.